-+ 0.00%
-+ 0.00%
-+ 0.00%

ARRIVENT BIOPHARMA - SAFETY PROFILE IN FURVENT CONSISTENT WITH PREVIOUS STUDIES, NO NEW SAFETY SIGNALS

Reuters·10/06/2026 12:02:13